Netscientific Share Discussion Threads

[loafofbread] 17/11/2022 08:30

Talk of a massive increase in funding for energy efficiency schemes.

Boiler grants, lofts etc.

Has to be a kicker for QBot going forward?!

[blakieboy7] 16/11/2022 12:15

Don't apologise Kingston!! This needs discussion

[kingston78] 16/11/2022 11:42

Sorry to keep on posting. For information only, the share is on an upward trajectory. On a weekly chart it has reached the upper band, however, there is momentum, and on a monthly chart its upper band is at 140 p.

[kingston78] 16/11/2022 11:34

I strongly believe that the best shares to hold in the current economic climate are in Technology and Biotech / Pharma sectors. It is unusual for a company such as Net Scientific to have invested in these totally diverse sectors. Any one of them may hit the jackpot worth far more than the current capitalisation.

[blakieboy7] 16/11/2022 10:03

Yes PDSB is motoring ahead - NSCI has lots of catching up to do

[kingston78] 16/11/2022 10:00

I have just checked and found out that PDSB went up 22.95% to US$ 8.68, which is more than double its price a few months ago.

[blakieboy7] 16/11/2022 09:18

It's long overdue Kingston!!

[kingston78] 16/11/2022 09:12

There was a small falling gap in the candle chart, which is now being filled. In charting terms, a falling gap becomes a resistance. Once this resistance is broken it will be blue sky. A few more pence to fill to break upwards.

[blakieboy7] 16/11/2022 08:20

Moving now

[blakieboy7] 16/11/2022 07:58

Hoping for some positive movement today

[loafofbread] 15/11/2022 21:56

PDSB worth £11M and cash worth £2M.

The rest of NSCI worth £2.5M even though the recent results have it down at £25M (less PDSB)

Looks like my PDSB take out at $20 before Xmas is on track.

[investordave] 15/11/2022 21:16

Here's hoping. It's long overdue.

[blakieboy7] 15/11/2022 20:49

PDSB now over 22% up - NSCI has to play catch up sooner or later

[blakieboy7] 15/11/2022 15:17

PDSB up over 13% so far

[bumpa33] 15/11/2022 11:21

Will take a look (at the others), the main interest for me is pds0101. Surely yesterdays phase2 news is a huge step forward in getting something else to work in combination with Mercks Keytruda, especially when others have failed. Worth multi billions to Merck potentially - after 2028 they’ll lose huge revenue once the patent for Keytruda runs out.

[blakieboy7] 15/11/2022 08:48

There are some real gems in the mix

[senttothegallows] 15/11/2022 08:47

Yes they have a real basket of assets.

Proaxis
Glycotest
EV Capital 100% owned is significant over £3.5m
Qbot investment worth over £2m
Sagetech
Sofant
The list goes on

IMHO

[bumpa33] 15/11/2022 08:45

Thanks again, will start by having a look at them :)

[blakieboy7] 15/11/2022 08:40

ProAxis and Glycotest for me!

[bumpa33] 15/11/2022 08:36

Many thanks 🙏 just one more question, after PDS who of the portfolio companies is the most prospective/exciting?

[senttothegallows] 15/11/2022 08:27

Over £1.50 all day long IMHO

[bumpa33] 15/11/2022 08:24

Anyone have a rough idea of current NAV?

[loafofbread] 15/11/2022 08:09

Small cap, no news, no interest.

You should be happy that you can pick these up for such a price.

[blakieboy7] 15/11/2022 07:58

Completely agree gallows, something doesn't add up here

[senttothegallows] 15/11/2022 07:29

Not sure how much longer share price can stay so far behind NAV. Soon PDSB value will exceed our market cap. IMHO